<DOC>
	<DOCNO>NCT01358396</DOCNO>
	<brief_summary>Does diabetic patient ' glycemic control affect response laser and/or intravitreal injection therapy term visual anatomical outcome .</brief_summary>
	<brief_title>Glycemic Control Diabetic Macular Edema</brief_title>
	<detailed_description>To evaluate visual anatomical response therapy patient diabetic macular edema ( DME ) relation glycemic control . Patients DME central foveal thickness ( CFT ) &gt; 250µm proliferative disease glycosolated hemoglobin ( HbA1c ) measure baseline 3 month . CFT optical coherence tomography , best correct visual acuity ( BCVA ) logMARs measure baseline , 1 , 3 month . Exclusion criterion : laser intravitreal injection within 6 month , hard exudate within 500um foveal center , macular traction . Therapy include laser intravitreal anti VEGFs . HbA1c grade : G1= &lt; 7 % , G2= 7-7.9 % , G3= 8-8.9 % , G4 = &gt; 9 % ; : low &lt; 8 % , high ≥ 8 % .</detailed_description>
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<criteria>Central foveal thickness 250 micron Proliferative Diabetic Retinopathy . Traction Macular Membranes Previous Laser intravitreal injection within 6 month .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>Diabetic Macular Edema , Glycemic Control</keyword>
</DOC>